Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kurt Vonfricken

Surgery Buffalo, NY Medical Doctor

NPI 1851351746 CMS profile 128911

100 High St, C3, Buffalo, NY 14203

Open in the dashboard

General payments

$16,277

366 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kurt Vonfricken of Buffalo, NY is reported in the CMS Open Payments database as having received $16,277 across 366 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,995 78
2024 General $3,986 73
2023 General $1,927 60
2022 General $2,609 57
2021 General $1,299 41
2020 General $413 20
2019 General $1,048 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kurt Vonfricken
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Kurt Vonfricken were reported at $4,995. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Kurt Vonfricken Surgery median Middle half National median
2019 $1,048 $253 $82–$1,521 $163
2020 $413 $131 $40–$706 $114
2021 $1,299 $168 $50–$904 $132
2022 $2,609 $224 $76–$1,218 $149
2023 $1,927 $253 $82–$1,255 $160
2024 $3,986 $279 $90–$1,381 $164
2025 $4,995 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $2,128 8 payments
  2. Philips Electronics North America Corporation $2,014 13 payments
  3. Edwards Lifesciences Corporation $1,826 70 payments
  4. Boston Scientific Corporation $1,826 69 payments
  5. Medtronic, Inc. $1,815 23 payments
  6. Abiomed $1,466 30 payments
  7. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,293 41 payments
  8. Atricure, Inc. $632 28 payments
  9. AOP Health US, LLC $542 1 payment
  10. Zimmer Biomet Holdings, Inc. $311 1 payment
  11. Other $2,423 82 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,048 348 payments
  2. Travel and Lodging $4,228 18 payments
Products named General payments · program years 2019–2025
  1. Micra $1,534 14 payments
  2. LifeVest $1,293 41 payments
  3. ANGIOVAC $1,270 3 payments
  4. (BS2) LM Undivided $1,197 4 payments
  5. Impella $1,132 24 payments
  6. ALPHAVAC $859 5 payments
  7. SAPIEN 3 Ultra RESILIA $688 21 payments
  8. Rapiblyk Cardiovascular $542 1 payment
  9. Rapiblyk Cardiovascular $542 1 payment
  10. EMBLEM MRI S-ICD $419 19 payments
  11. Other $7,053 254 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$35,757

Medicare's payments for the services billed

Medicare patients

97

Average age 74

Services billed

249

40 women, 57 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 74%
Atrial fibrillation 62%
Chronic kidney disease 62%
Diabetes 56%
Arthritis 56%
COPD 45%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

366 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record